Home › Metastatic Cancer › Illinois › North Peoria
Metastatic Cancer clinical trials in North Peoria, IL
3 studies for Metastatic Cancer are looking for participants at sites in and around North Peoria (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Illinois CancerCare - Washington, Washington · 9 mi away
- Illinois CancerCare-Eureka, Eureka · 16 mi away
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Illinois CancerCare-Washington, Washington · 9 mi away
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Illinois CancerCare-Washington, Washington · 9 mi away
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in North Peoria
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer9 studies
- Colorectal Cancer7 studies
- Prostate Cancer6 studies
- Head and Neck Squamous Cell Carcinoma5 studies
- Breast Cancer5 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Pancreatic Cancer4 studies
- Melanoma4 studies
- Hypopharyngeal Cancer4 studies
- Laryngeal Cancer4 studies
- Oral Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.